Furthermore, MRE11 is supposed as a potential target for cancer therapy, since inhibitors to MRE11 exhibited promising therapeutic effects in cancer cells, either as favorable sensitizers or antitumor agents [72,73]. The gene discussed is MRE11; the disease is cancer.